Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
15.01
-1.07 (-6.65%)
Feb 20, 2026, 4:00 PM EST - Market closed

Select Medical Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,4535,1874,8264,6096,205
Revenue Growth (YoY)
5.12%7.48%4.70%-25.71%12.16%
Cost of Revenue
4,5284,2723,9903,9544,941
Gross Profit
924.8915.54836.47655.591,264
Selling, General & Admin
449.92507.76435.06407.13491.12
Other Operating Expenses
-1.59-3.41-1.52--0.33
Operating Expenses
588.63647.22569.23539.29693.43
Operating Income
336.17268.32267.24116.3570.07
Interest Expense
-117.94-128.61-154.17-137.47-135.99
Interest & Investment Income
----5.35
Earnings From Equity Investments
54.5263.941.3427.9844.43
EBT Excluding Unusual Items
272.75203.61154.426.81483.87
Gain (Loss) on Sale of Assets
----2.16
Legal Settlements
----19.9
Other Unusual Items
--28.85-14.6928.45123.8
Pretax Income
272.75174.77139.7235.27629.72
Income Tax Expense
58.2244.7829.2516.72129.77
Earnings From Continuing Operations
214.53129.99110.4718.55499.95
Earnings From Discontinued Operations
-166.72189.26179.48-
Net Income to Company
214.53296.7299.73198.03499.95
Minority Interest in Earnings
-68.31-82.67-56.24-39.03-97.72
Net Income
146.22214.04243.49158.99402.23
Preferred Dividends & Other Adjustments
3.352.322.13-0.5313.44
Net Income to Common
142.87211.72241.36159.52388.79
Net Income Growth
-31.69%-12.10%53.14%-60.47%55.30%
Shares Outstanding (Basic)
123125123125130
Shares Outstanding (Diluted)
123125123125130
Shares Change (YoY)
-1.58%1.23%-1.22%-4.32%0.36%
EPS (Basic)
1.161.701.961.282.98
EPS (Diluted)
1.161.701.961.282.98
EPS Growth
-31.44%-13.35%53.18%-57.12%54.90%
Free Cash Flow
117.24295.69352.8694.45220.69
Free Cash Flow Per Share
0.962.372.870.761.69
Dividend Per Share
0.2500.5000.5000.5000.500
Dividend Growth
-50.00%----
Gross Margin
16.96%17.65%17.33%14.22%20.36%
Operating Margin
6.17%5.17%5.54%2.52%9.19%
Profit Margin
2.62%4.08%5.00%3.46%6.27%
Free Cash Flow Margin
2.15%5.70%7.31%2.05%3.56%
EBITDA
476.47411.18402.93248.46772.72
EBITDA Margin
8.74%7.93%8.35%5.39%12.45%
D&A For EBITDA
140.3142.87135.69132.16202.65
EBIT
336.17268.32267.24116.3570.07
EBIT Margin
6.17%5.17%5.54%2.52%9.19%
Effective Tax Rate
21.34%25.62%20.94%47.42%20.61%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q